Please assess the completion status of the following clinical trial:

Trial Title: Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inflammatory Bowel Disease (IBD) or suspected IBD~* Planned Endoscopy~* Candidate for propofol sedation~* willingness to be randomized~* Ability to complete questionnaire~Exclusion Criteria:~* Allergy to drugs~* American Society of Anesthesiologists Class III~* Body Mass Index \> 35~* Ventricular retention~* Acute condition~* Severe Chronic obstructive pulmonary disease~* Sleep apnea~* Potentially difficult airway or previous difficulty with anesthesia~* Pregnancy~* \<18 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Propofol (Type: EXPERIMENTAL): Propofol in refract doses. Induction: 10-60 mg supplemented with 10-30 mg following an age correlated algorithm. Maintenance with refract bolus of 10-20 mg every 1-2 minutes after assessed need and condition
- Fentanyl and Midazolam (Type: ACTIVE_COMPARATOR): 0.025-0.05 mg of Fentanyl i.v. minimum 5 minutes before procedure as a single shot. Midazolam 1-2 mg i.v. for induction and 0.5-1 mg i.v. for maintenance after assessing needs and condition

Based on this trial design, predict the completion outcome and termination type (if applicable).